- Home
- SNGX vs ASST Comparison
SNGX vs ASST Comparison
Compare SNGX & ASST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- ASST
- Stock Information
- Founded
- SNGX 1987
- ASST 2020
- Country
- SNGX United States
- ASST United States
- Employees
- SNGX N/A
- ASST N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- ASST Computer Software: Prepackaged Software
- Sector
- SNGX Health Care
- ASST Technology
- Exchange
- SNGX Nasdaq
- ASST Nasdaq
- Market Cap
- SNGX 6.1M
- ASST 7.2M
- IPO Year
- SNGX 1987
- ASST 2023
- Fundamental
- Price
- SNGX $1.89
- ASST $0.54
- Analyst Decision
- SNGX
- ASST
- Analyst Count
- SNGX 0
- ASST 0
- Target Price
- SNGX N/A
- ASST N/A
- AVG Volume (30 Days)
- SNGX 29.1K
- ASST 1.7M
- Earning Date
- SNGX 05-09-2025
- ASST 05-14-2025
- Dividend Yield
- SNGX N/A
- ASST N/A
- EPS Growth
- SNGX N/A
- ASST N/A
- EPS
- SNGX N/A
- ASST N/A
- Revenue
- SNGX $119,371.00
- ASST $633,489.00
- Revenue This Year
- SNGX N/A
- ASST N/A
- Revenue Next Year
- SNGX N/A
- ASST N/A
- P/E Ratio
- SNGX N/A
- ASST N/A
- Revenue Growth
- SNGX N/A
- ASST 93.55
- 52 Week Low
- SNGX $1.83
- ASST $0.34
- 52 Week High
- SNGX $14.88
- ASST $3.94
- Technical
- Relative Strength Index (RSI)
- SNGX 33.66
- ASST 51.58
- Support Level
- SNGX $2.25
- ASST $0.48
- Resistance Level
- SNGX $2.28
- ASST $0.72
- Average True Range (ATR)
- SNGX 0.11
- ASST 0.05
- MACD
- SNGX -0.02
- ASST 0.01
- Stochastic Oscillator
- SNGX 0.11
- ASST 37.35
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About ASST Asset Entities Inc. Class B
Asset Entities Inc is an Internet company providing social media marketing, content delivery, and development and design services across Discord, TikTok, and other social media platforms. It has three categories of services: 1) provide subscription upgrades to premium content on investment education and entertainment servers on Discord. 2) codevelop and execute influencer social media and marketing campaigns for clients. 3) design, develop and manage Discord servers for clients under "AE.360.DDM" brand.